99 related articles for article (PubMed ID: 8585116)
1. Enantioselective determination of mianserin and its desmethyl metabolite in plasma during treatment of depressed Japanese patients.
Tybring G; Otani K; Kaneko S; Mihara K; Fukushima Y; Bertilsson L
Ther Drug Monit; 1995 Oct; 17(5):516-21. PubMed ID: 8585116
[TBL] [Abstract][Full Text] [Related]
2. Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients.
Yasui N; Tybring G; Otani K; Mihara K; Suzuki A; Svensson JO; Kaneko S
Pharmacogenetics; 1997 Oct; 7(5):369-74. PubMed ID: 9352572
[TBL] [Abstract][Full Text] [Related]
3. Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients.
Eap CB; Powell K; Campus-Souche D; Monney C; Baettig D; Taeschner W; Baumann P
Chirality; 1994; 6(7):555-63. PubMed ID: 7986669
[TBL] [Abstract][Full Text] [Related]
4. Steady-state plasma concentrations of mianserin and its major active metabolite, desmethylmianserin.
Otani K; Sasa H; Kaneko S; Kondo T; Fukushima Y
Ther Drug Monit; 1993 Apr; 15(2):113-7. PubMed ID: 8503138
[TBL] [Abstract][Full Text] [Related]
5. The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients.
Mihara K; Otani K; Tybring G; Dahl ML; Bertilsson L; Kaneko S
J Clin Psychopharmacol; 1997 Dec; 17(6):467-71. PubMed ID: 9408809
[TBL] [Abstract][Full Text] [Related]
6. Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients.
Otani K; Tybring G; Mihara K; Yasui N; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
Eur J Clin Pharmacol; 1998 Jan; 53(5):347-9. PubMed ID: 9516035
[TBL] [Abstract][Full Text] [Related]
7. Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine.
Eap CB; Lima CA; Macciardi F; Woggon B; Powell K; Baumann P
Ther Drug Monit; 1998 Feb; 20(1):7-13. PubMed ID: 9485547
[TBL] [Abstract][Full Text] [Related]
8. Prediction of plasma concentrations of mianserin and desmethylmianserin at steady state from those after an initial dose of mianserin.
Otani K; Mihara K; Okada M; Tanaka O; Kaneko S; Fukushima Y
Ther Drug Monit; 1993 Apr; 15(2):118-21. PubMed ID: 8503139
[TBL] [Abstract][Full Text] [Related]
9. Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites.
Eap CB; Yasui N; Kaneko S; Baumann P; Powell K; Otani K
Ther Drug Monit; 1999 Apr; 21(2):166-70. PubMed ID: 10217335
[TBL] [Abstract][Full Text] [Related]
10. Analytical method development and validation of mianserin hydrochloride and its metabolite in human plasma by LC-MS.
Chauhan B; Rani S; Guttikar S; Zope A; Jadon N; Padh H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):69-74. PubMed ID: 16006201
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism.
Dahl ML; Tybring G; Elwin CE; Alm C; Andreasson K; Gyllenpalm M; Bertilsson L
Clin Pharmacol Ther; 1994 Aug; 56(2):176-83. PubMed ID: 8062494
[TBL] [Abstract][Full Text] [Related]
12. Subjective side effects of mianserin in relation to plasma concentrations of mianserin and desmethylmianserin.
Otani K; Sasa H; Higuchi H; Kaneko S; Hishikawa Y; Fukushima Y
Ther Drug Monit; 1992 Jun; 14(3):190-3. PubMed ID: 1412603
[TBL] [Abstract][Full Text] [Related]
13. Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography.
Dodd S; Burrows GD; Norman TR
J Chromatogr B Biomed Sci Appl; 2000 Oct; 748(2):439-43. PubMed ID: 11087086
[TBL] [Abstract][Full Text] [Related]
14. New method for the chiral evaluation of mirtazapine in human plasma by liquid chromatography.
de Santana FJ; Cesarino EJ; Bonato PS
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):351-6. PubMed ID: 15315787
[TBL] [Abstract][Full Text] [Related]
15. A simpler and faster capillary electrophoresis method for determination of mianserin enantiomers in human serum.
Grodner B; Pachecka J
Acta Pol Pharm; 2006; 63(1):9-14. PubMed ID: 17515323
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients.
Dawling S; Ford S; Ariyanayagam P; O'Neal H; Lewis RR
Clin Pharmacokinet; 1987 Jan; 12(1):73-8. PubMed ID: 3816006
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological aspects of mianserin.
Pinder RM; van Delft AM
Acta Psychiatr Scand Suppl; 1983; 302():59-71. PubMed ID: 6301219
[TBL] [Abstract][Full Text] [Related]
18. A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.
Riley RJ; Lambert C; Kitteringham NR; Park BK
Br J Clin Pharmacol; 1989 Jun; 27(6):823-30. PubMed ID: 2757897
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine enantiomers in blood and cerebrospinal fluid.
Baumann P; Jonzier-Perey M; Paus E; Nikisch G
Neuropsychobiology; 2006; 54(3):179-81. PubMed ID: 17230030
[TBL] [Abstract][Full Text] [Related]
20. Determination of mianserin in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-ESI/MS): application to a bioequivalence study in Chinese volunteers.
Xu P; Li HD; Chen BM; Ma N; Yan M; Zhu YG
J Pharm Biomed Anal; 2008 Aug; 47(4-5):994-9. PubMed ID: 18514457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
